openPR Logo

Press Releases from SpectraCell Laboratories, Inc. (3 total)

SpectraCell Announces 2012 Webinar Series

Houston, TX- January 31, 2012. SpectraCell announces the first half of its 2012 lineup of educational webinars. Although the presentation content is geared toward physicians, they are free to the public and emphasize the clinical implications of nutritional deficiencies on health and disease: SpectraCell 2012 Webinar Series: January – Telomere Testing: A New Tool for Your Age Management Practice presented by: Dr. Dian Ginsberg, MD, OB/Gyn in Houston, Clinical Director

SpectraCell Now Offers LPP Cardiovascular Testing in New York

Houston, TX – April 26, 2011. SpectraCell Laboratories has officially been granted a license to provide its Lipoprotein Particle Profile™ (LPP™) test, which assesses cardiovascular risk, to New York state physicians and patients. The recently patented LPP™ test has been commercially available to the other 49 states since 2006. SpectraCell began the process of acquiring a licensure in 2008 with an application submission the state of New York.

SpectraCell Receives Patent on its LPP Cardiovascular Test

Houston, TX - February 7, 2011. SpectraCell Laboratories has recently been awarded a patent on their Lipoprotein Particle Profile™ (LPP ™) test which is used to measure cardiovascular risk. The LPP™ has been commercially available since 2006, and is a type of advanced cholesterol test that measures lipoprotein subgroups. The LPP™ gives more accurate estimation of cardiovascular risk compared to a routine cholesterol test. The patent

Go To Page:   1 2 3 4 5 6 7 8 9 10